Search research articles
Contact Us
Filters
Showing results (701-710 of 921) with videos related to
Page
of 93
Sort By:
Science (New York, N.Y.)
|
March 7, 1986
Atrial natriuretic peptide elevation in congestive heart failure in the human
J C Burnett, P C Kao, D C Hu, et al.
Clinical Chemistry
|
July 3, 2014
High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population
Paul M McKie, Omar F AbouEzzeddine, Christopher G Scott, et al.
Journal of Pediatric Surgery
|
February 12, 2021
Cognitive, academic, and behavioral functioning in school-aged children born with esophageal atresia
Alice C Burnett, Julia K Gunn-Charlton, Stephanie Malarbi, et al.
American Journal of Physiology. Renal Physiology
|
August 26, 2011
Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging
S Jeson Sangaralingham, Denise M Heublein, Joseph P Grande, et al.
Circulation
|
August 1, 1993
Molecular forms of atrial natriuretic factor in normal and failing human myocardium
R J Rodeheffer, M Naruse, J B Atkinson, et al.
Journal of the American College of Cardiology
|
May 8, 2010
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
Paul M McKie, Alessandro Cataliotti, Brian D Lahr, et al.
Cardiovascular Research
|
August 4, 2010
A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway
Ana Kilic, Venkatesh Rajapurohitam, Sharon M Sandberg, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 26, 2009
Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease
J C Burnett, C Wang, J E Nuss, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1996
Angiotensin II in the evolution of experimental heart failure
A Luchner, T L Stevens, D D Borgeson, et al.
Journal of Cardiovascular Pharmacology
|
May 22, 1998
Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis
J A Grantham, J A Schirger, E E Williamson, et al.
Page
of 93
Search research articles
Search
Showing results (701-710 of 921) with videos related to
Sort By:
Page
of 93
Science (New York, N.Y.)
|
March 7, 1986
Atrial natriuretic peptide elevation in congestive heart failure in the human
J C Burnett, P C Kao, D C Hu, et al.
Clinical Chemistry
|
July 3, 2014
High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population
Paul M McKie, Omar F AbouEzzeddine, Christopher G Scott, et al.
Journal of Pediatric Surgery
|
February 12, 2021
Cognitive, academic, and behavioral functioning in school-aged children born with esophageal atresia
Alice C Burnett, Julia K Gunn-Charlton, Stephanie Malarbi, et al.
American Journal of Physiology. Renal Physiology
|
August 26, 2011
Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging
S Jeson Sangaralingham, Denise M Heublein, Joseph P Grande, et al.
Circulation
|
August 1, 1993
Molecular forms of atrial natriuretic factor in normal and failing human myocardium
R J Rodeheffer, M Naruse, J B Atkinson, et al.
Journal of the American College of Cardiology
|
May 8, 2010
The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects
Paul M McKie, Alessandro Cataliotti, Brian D Lahr, et al.
Cardiovascular Research
|
August 4, 2010
A novel chimeric natriuretic peptide reduces cardiomyocyte hypertrophy through the NHE-1-calcineurin pathway
Ana Kilic, Venkatesh Rajapurohitam, Sharon M Sandberg, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 26, 2009
Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease
J C Burnett, C Wang, J E Nuss, et al.
Hypertension (Dallas, Tex. : 1979)
|
September 1, 1996
Angiotensin II in the evolution of experimental heart failure
A Luchner, T L Stevens, D D Borgeson, et al.
Journal of Cardiovascular Pharmacology
|
May 22, 1998
Enhanced endothelin-converting enzyme immunoreactivity in early atherosclerosis
J A Grantham, J A Schirger, E E Williamson, et al.
Page
of 93